Certain Common Stock of Appirits Inc. are subject to a Lock-Up Agreement Ending on 25-MAY-2021. These Common Stock will be under lockup for 89 days starting from 25-FEB-2021 to 25-MAY-2021. Details: In connection with this offer and the sale of underwriters by accepting purchase transactions, Cryptomeria Co., Ltd., a seller and lender; the seller, ATGC Co., Ltd.; our shareholders, Koichi Uotani, Junji Wada, Shinya Kasaya, Miura Printing Corporation, Jun Mihara, Take and Give Needs Co., Ltd., Hiromichi Yagi, Hideki Tomita, Manabu Nishiwaki, Kenichi Kito, Ryuichi Toshida, BONNET Co., Ltd., Masahiro Kotosaka , Takeshi Okouchi, Naohiro Ishigami, Eisuke Ito; and our stock acquisition rights holders, Toru Nagayama, Takumi Ozawa, Wataru Hase, Toshio Suzuki, Ryo Koyama, Aiko Kawaguchi, Ippo Murakami, Yasushi Toyama, Hiroki Yoshida, Shuji Sado, Hiroki Aoi, Shogo Ogane, Tsutomu Hasebe, Hiroki Minami , Yasuhiro Otsuka, have agreed with the lead manager that during the period from the date of signing the principal underwriting contract to the 180th day (August 23, 2021) after the listing date (including the day), they will not sell our common stock without the prior written consent of the lead managing underwriter (However, this excludes the lending of the Company's common stock for sale by underwriting purchase transactions and sale by over-allotment.). The Company has agreed with the lead managing underwriter that, during the period from the conclusion of the original underwriting contract to the 180th day (August 23, 2021) after the listing date (including the day), without the prior written consent of the lead managing underwriter, we will not issue the Company's common stock, securities that will be converted or exchanged for the Company's common stock, or securities that have been granted the right to acquire or receive the Company's common stock (However, the lead managing underwriter resolved at the Board of Directors meeting held on January 20, 2021 in connection with the offering, stock split, issuance of stock acquisition rights as stock options, and sale by over-allotment will be the allottee. Excludes capital increase through third-party allotment.) In addition, HBD Co., Ltd., Naotake Hibiya and Mizuho Capital Co., Ltd., which are our shareholders, have agreed with the lead managing underwriter that during the period from the date of signing the original underwriting contract to the 90th day (May 25, 2021) after the listing date (including the day), without the prior written consent of the lead managing underwriter, they will not sell our common stock (However, the sale price is 1.5 times or more the issue price in the "1st Offering Guidelines" and excludes sales on the Tokyo Stock Exchange through the lead managing underwriter.)